Mark Roschewski is a Hematologist in Washington, Washington, D.c.. Dr. Roschewski is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are B-Cell Lymphoma, Smoldering Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Vitrectomy.

Wyndham Wilson is an Oncologist in Bethesda, Maryland. Dr. Wilson is rated as an Elite provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Burkitt Lymphoma.

Kieron Dunleavy is an Oncologist and a Hematologist in Washington, Washington, D.c.. Dr. Dunleavy is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Primary Mediastinal B-Cell Lymphoma (PMBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Burkitt Lymphoma, and Bone Marrow Aspiration. Dr. Dunleavy is currently accepting new patients.

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Xiaojun Wu, M.D., Ph.D. is as assistant professor of pathology at Sibley Memorial Hospital where she will lead their hematopathology program. Dr. Wu received her M.D. from Zhejiang Medical University in China, and her Ph.D. from the University of Alabama at Birmingham. She continued at the University of Alabama at Birmingham for pathology residency training, followed by a fellowship in hematopathology. She then moved to New York where she completed a surgical pathology fellowship at Memorial Sloan Kettering Cancer Center. She subsequently joined the faculty at New York University from 2013-2015 and moved to the Washington area in 2015 and joined the faculty at George Washington University from 2015-2016. She has been with Johns Hopkins since 2016. Dr. Wu has 15 peer-reviewed publications, primarily in the field of hematopathology. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Acute Myeloid Leukemia (AML).

Jillian Simard is a fellowship-trained medical oncologist with a focus on breast cancer. She sees patients at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, and is a clinical associate for the Johns Hopkins University School of Medicine. Dr. Simard brings a multidisciplinary background in patient care, translational research and clinical trials, with a particular interest in improving outcomes for patients with breast cancer through personalized and evidence-based treatment strategies. Dr. Simard received her medical degree from the UCSF School of Medicine, followed by a residency in internal medicine at Northwestern University McGaw Medical Center, where she was part of the Women’s Health Track and received a Resident Teaching Award. She then completed a clinical fellowship in medical oncology at the National Cancer Institute (NCI), where she also served as a research fellow in the Lymphoid Malignancies Branch. During her time at the NCI, Dr. Simard participated in multiple clinical research efforts, including serving as lead associate investigator for a Phase 2 trial for secondary CNS lymphoma. Her research portfolio includes designing early-phase clinical trials and contributing to peer-reviewed publications in journals such as the New England Journal of Medicine and Clinical Lymphoma, Myeloma & Leukemia. Dr. Simard is committed to fostering compassionate, equitable care and to working collaboratively across disciplines to improve patient outcomes. Dr. Simard is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Febrile Neutropenia, Agranulocytosis, B-Cell Lymphoma, and Non-Hodgkin Lymphoma.

Scott Rowley is an Oncologist and a Hematologist in Washington, Washington, D.c.. Dr. Rowley is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Colonoscopy.

Mitchell Smith is an Oncologist and a Hematologist in Washington, Washington, D.c.. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma, Mantle Cell Lymphoma (MCL), and Bone Marrow Transplant.

Kamyar Nader is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Nader is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Sickle Cell Disease, Follicular Lymphoma, and Bone Marrow Aspiration.

Aarthi Shenoy is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Shenoy is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration.

Maryam Sarraf-Yazdy is a primary care provider, practicing in Internal Medicine in Washington, Washington, D.c.. Dr. Sarraf-Yazdy is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, Marginal Zone Lymphoma (MZL), and Chronic B-Cell Leukemia (CBCL).

Nicholas Farrell is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Farrell is rated as an Advanced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Iron Deficiency Anemia.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Bruce Cheson is a Hematologist and a Hematologist Oncology provider in Bethesda, Maryland. Dr. Cheson is rated as a Distinguished provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Follicular Lymphoma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, and Bone Marrow Transplant. Dr. Cheson is currently accepting new patients.

Samah Nassereddine is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Nassereddine is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Hodgkin Lymphoma, Iron Deficiency Anemia, Acute Myeloid Leukemia (AML), Colonoscopy, and Endoscopy.

Robert Siegel is a Hematologist in Washington, Washington, D.c.. Dr. Siegel is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Myelodysplastic Syndrome (MDS), Anemia, Thrombocytopenia, and Chronic Lymphocytic Leukemia (CLL).

Pavani Chalasani is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Chalasani is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Chalasani is currently accepting new patients.

Ravi Sarma is a Hematologist Oncology specialist and a Hematologist in Washington, Washington, D.c.. Dr. Sarma is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). His top areas of expertise are Anemia, Breast Cancer, Thrombocytopenia, and Paget Disease of the Breast.

Vera Malkovska is a Hematologist in Washington, Washington, D.c.. Dr. Malkovska is rated as an Experienced provider by MediFind in the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). Her top areas of expertise are Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma, Sickle Cell Disease, and Bone Marrow Aspiration.